Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9

Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9

Recently we showed that delta radiomics features (DRF) from daily CT-guided chemoradiation therapy (CRT) is associated with early prediction of treatment response for pancreatic cancer. CA19-9 is a widely used clinical biomarker for pancreatic cancer. The purpose of this work is to investigate if th...

Full description

Bibliographic Details
Main Authors: Haidy Nasief, William Hall, Cheng Zheng, Susan Tsai, Liang Wang, Beth Erickson, X. Allen Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Oncology
Subjects:
pancreatic cancer
survival
CA19-9
biomarkers
chemo-radiation therapy
response assessment
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01464/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01464/full

Similar Items